BioSpace News Archive

Business

Interim Report January-September 2023

Net sales amounted to SEK 146.6 million (96.8), corresponding to an increase of 51 percent in SEK and 42 percent in local currencies. • Organic growth accounted for 37 percent and acquired growth for 5 percent.

October 24, 2023
·
5 min read
Turbine Establishes Research Collaboration with Ono Pharmaceutical to Identify and Validate Novel Oncology Targets

Turbine, a computational biology company that deploys empirically validated in silico cell simulations to guide biopharma R&D, announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd to identify and validate novel targets within one of Ono’s priority domains of cancer biology.

October 24, 2023
·
4 min read
Drug Development

Genascence to Present Full Data from Phase 1 Clinical Trial on GNSC-001, Company’s Lead Program in Osteoarthritis, at European Society of Gene & Cell Therapy 30th Annual Congress

Genascence Corporation announced that data from the Phase 1 clinical trial of GNSC-001 for the treatment of osteoarthritis demonstrated that it was safe and well tolerated.

October 24, 2023
·
5 min read
Life Molecular Imaging and Sinotau Pharmaceutical Group Announce the Regulatory Approval of their Amyloid PET Imaging Radiopharmaceutical Neuraceq® in China

Life Molecular Imaging and Sinotau Pharmaceutical Group are pleased to announce Neuraceq® has received regulatory approval from National Medical Products Administration in China.

October 24, 2023
·
7 min read
Business

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023

SOPHiA GENETICS SA, a cloud-native software company and a leader in data-driven medicine, announced it will release its financial results for the third quarter of fiscal 2023 before U.S. markets open on Tuesday, November 7, 2023.

October 24, 2023
·
1 min read
Business

Centene Corporation Reports Third Quarter 2023 Results

Centene Corporation announced its financial results for the third quarter ended September 30, 2023.

October 24, 2023
·
34 min read
Biotech Bay

Annexon Receives PRIME Designation from the EMA for ANX007 for the Treatment of Geographic Atrophy

Annexon, Inc. announced that the European Medicines Agency has granted Priority Medicine designation to ANX007 for the treatment of geographic atrophy secondary to age-related macular degeneration.

October 24, 2023
·
7 min read
Business

Quest Diagnostics Reports Third Quarter 2023 Financial Results; Updates Guidance for Full Year 2023

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced financial results for the third quarter ended September 30, 2023.

October 24, 2023
·
18 min read
Pharm Country

Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting

Globus Medical, Inc., a leading musculoskeletal solutions company, presented five-year outcomes from the NuVasive Simplify Cervical Disc study at the North American Spine Society 38th Annual Meeting.

October 24, 2023
·
5 min read
Lone Star Bio

Bio-Path Holdings to Host Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid Leukemia

Bio-Path Holdings, Inc. announced it will host a virtual key opinion leader event to highlight the prexigebersen program and discuss advances in the treatment landscape for acute myeloid leukemia.

October 24, 2023
·
1 min read